The report segments the organ preservation market based on preservation solution, technique and organ type. The University of Wisconsin solution segment is expected to account for the largest share of the market, by preservation solution in 2016 and is expected to grow at highest CAGR.
This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs.
Target Audience for this Report:
# Preservation Solutions and Devices Providers
# Life Sciences Companies
# Medical Device Manufacturers
# Market Research and Consulting Firms
# Healthcare Service Providers
# Medical Research Institutes
# Regulatory Bodies
# Venture Capitalists
Find More Details | Get the Sample Pages@
Factors Influencing Global Growth:-
The growth of the overall market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global market.
# High Cost of Organ Transplantation
# Normothermic Machine Perfusion: A New Paradigm for Organ Preservation
# Significant Gap Between Number of Organs Donated and Organs Required Annually
# Limited Medical Reimbursements for Organ Donation and Transplantation
Monetary Growth Expectations, Globally:
The market is expected to reach USD 241.2 Million by 2021 from USD 165.9 Million in 2016 at a CAGR of 7.8% during the forecast period.
Geographical Growth Scenario:
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the organ preservation market. Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players.
However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to the new regulatory framework in China, and increasing organ donations in Asia-Pacific and serve as a revenue pocket for companies offering organ preservation solutions and transport systems
Talk to Our Research Experts@
Leading Market Players:
# Organ Recovery Systems (U.S.)
# Xvivo Perfusion AB (Sweden)
# Essential Pharmaceuticals LLC (U.S.)
# Dr. Franz Kohler Chemie GmbH (Germany)
# Waters Medical Systems LLC (U.S. and many more…
Client acquisitions, approvals & certifications, market expansions, and other (product launches and integrations, agreements, and contracts) are the major developments undertaken by the players to achieve growth in this market. Client acquisitions accounted for ~41% of the total developments undertaken by the players in this market.